Wexford Labs. Inc. – Trademark Portfolio

Entity Type: 03

Wexford Labs. Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CLEANCIDE, PUREFEXION, and WEXFORD LABS. The owner is based in Kirkwood, MO.

325 Leffingwell

Kirkwood, MO 63122

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Wexford Labs. Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Wexford Labs. Inc. have?

Wexford Labs. Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.

What trademark classes does Wexford Labs. Inc. file in?

Wexford Labs. Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Wexford Labs. Inc.'s most well-known trademarks?

Wexford Labs. Inc.'s registered trademark portfolio includes well-known marks such as CLEANCIDE, PUREFEXION, and WEXFORD LABS. These are among 3 currently registered trademarks in the portfolio.

What is Wexford Labs. Inc.'s trademark registration success rate?

Wexford Labs. Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.